VTR
69
2
ETN
57
2
KO
46
2
PRU
60
-2
LLY
84
13
AES
54
7
AVB
39
5
NOV
55
3
CVS
40
3
FTI
64
-5
A
51
8
AIZ
80
2
STI
21
3
WYNN
48
-2
NWSA
79
15
TXN
52
2
LMT
62
3
ZBH
44
2
THC
48
2
ACN
54
-2
VTR
69
2
ETN
57
2
KO
46
2
PRU
60
-2
LLY
84
13
AES
54
7
AVB
39
5
NOV
55
3
CVS
40
3
FTI
64
-5
A
51
8
AIZ
80
2
STI
21
3
WYNN
48
-2
NWSA
79
15
TXN
52
2
LMT
62
3
ZBH
44
2
THC
48
2
ACN
54
-2
Financhill
Back

ClearShares Ultra-Short Maturity ETF Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
59

OPER
ClearShares Ultra-Short Maturity ETF

Last Price:
$100.25
Seasonality Move:
-0.09%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$31.98
Seasonality Move:
-10.99%
Buy
59
ClearShares Ultra-Short Maturity ETF (OPER) is a Buy

Is ClearShares Ultra-Short Maturity ETF a Buy, Sell or Hold?

  • The current ClearShares Ultra-Short Maturity ETF [OPER] share price is $100.25. The Score for OPER is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • OPER is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OPER Stock Price Chart

What is ClearShares Ultra-Short Maturity ETF's stock price today?

  • The ClearShares Ultra-Short Maturity ETF share price today is $100.25
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OPER is experiencing slight buying pressure.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

OPER Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 62.86 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.06 - 100.26) Buy
Bollinger Bands (100): (100.1 - 100.34) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

OPER Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 100.19 Buy
20-day SMA: 100.14 Buy
50-day SMA: 100.17 Buy
200-day SMA: 100.25 Buy
8-day EMA: 100.2 Buy
20-day EMA: 100.16 Buy
50-day EMA: 98.48 Buy
200-day EMA: 64.07 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

ClearShares Ultra-Short Maturity ETF Earnings Growth & OPER Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

ClearShares Ultra-Short Maturity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):